Home Cart Sign in  
Chemical Structure| 130477-52-0 Chemical Structure| 130477-52-0

Structure of L-655708
CAS No.: 130477-52-0

Chemical Structure| 130477-52-0

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

L-655708 is an effective, selective GABAA receptor inverse agonist with a Ki of 0.45 nM.

Synonyms: L-655708

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of L-655708

CAS No. :130477-52-0
Formula : C18H19N3O4
M.W : 341.36
SMILES Code : COC1=CC=C(C2=C1)N3C=NC(C(OCC)=O)=C3[C@@]4([H])N(CCC4)C2=O
Synonyms :
L-655708
MDL No. :MFCD02684528

Safety of L-655708

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302-H315-H319
Precautionary Statements:P501-P270-P264-P280-P302+P352-P337+P313-P305+P351+P338-P362+P364-P332+P313-P301+P312+P330

Isoform Comparison

Biological Activity

In Vivo:

Species
Animal Model
Administration Dosage Frequency Description References
18-month-old C57BL/6J mice Laparotomy-induced perioperative neurocognitive disorder model Intraperitoneal injection 0.5 mg/kg Once daily for 3 consecutive days To determine whether inhibition of α5GABA ARs prevents cognitive deficits. Results showed that L-655708 improved spatial reference learning and memory ability in mice subjected to anesthesia and surgery. J Neuroinflammation. 2021 Sep 16;18(1):204
Sprague-Dawley rats Forced Swim Test (FST) and Open Field Test Intraperitoneal injection (i.p.) 3 mg/kg Single administration, tests conducted 24 hours or 7 days after administration To investigate the antidepressant-like effects of L-655708 and its mechanisms. Results showed that L-655708 significantly reduced immobility time and increased swimming behavior in the forced swim test, with effects lasting up to 7 days post-administration. Additionally, L-655708 increased GluA1 levels in the medial prefrontal cortex (mPFC) and enhanced neuronal excitability by reducing inhibitory postsynaptic current (IPSC) half-width and increasing action potential frequency in ventral hippocampal CA1 neurons. Neuropsychopharmacology. 2020 Dec;45(13):2289-2298
Mice Repeated mild traumatic brain injury model Subcutaneous administration 200 μg/kg/day Continued for 12 days Prevention of neurovascular impairments induced by mTBI, including reduced neuronal reactivity and increased venular blood flow speed Theranostics. 2021 Jun 16;11(16):7685-7699
Wistar rats Isoflurane-induced memory impairment model Subcutaneous injection 0.7 mg/kg Single dose, 30 minutes before anesthesia or 23.5 hours after anesthesia To investigate the preventive and therapeutic effects of L-655708 on isoflurane-induced memory impairment in aged rats. Results showed that L-655708 administered before anesthesia could prevent memory impairment, but administration after anesthesia could not reverse the impairment. Neural Regen Res. 2019 Jun;14(6):1029-1036
Female Wistar rats Formalin-induced long-lasting secondary allodynia and hyperalgesia Peripheral and intrathecal administration 0.15–15 nmol Single administration, effects assessed 1 hour post-injection L-655708 prevented and reversed formalin-induced long-lasting secondary allodynia and hyperalgesia Pain. 2016 Mar;157(3):613-626
Rats Chronic Restraint Stress (CRS) and Chronic Unpredictable Stress (CUS) Intraperitoneal injection 0.7 mg/kg Single injection, tested after 24 hours L-655708 reversed the alterations in hedonic behavior in the sucrose preference and social interaction tests produced by two different chronic stress paradigms in rats within 24 h of systemic administration, restored the strength of excitatory synaptic transmission, and increased levels of the GluA1 subunit of the AMPA receptor. Neuropsychopharmacology. 2015 Oct;40(11):2499-509
Rats ET-1-induced focal ischemia model Subcutaneous implantation 1.5 mg/L Every 24 hours for 2 weeks To evaluate the effects of L-655708 on brain anatomy and forelimb skilled reaching, results showed a progressive decrease in total stroke volume (13±4 mm3 per week) and improvement in skilled reaching (9%±1% per week) J Cereb Blood Flow Metab. 2015 Oct;35(10):1601-9
Female C57BL/6J mice Laparotomy model Intraperitoneal injection 0.5 mg/kg L655,708 reversed laparotomy-induced hippocampus-dependent memory deficits and long-term potentiation (LTP) impairment. CNS Neurosci Ther. 2020 Sep;26(9):913-924
Sprague-Dawley rats Alcohol Deprivation Effect (ADE) model Intraperitoneal injection 0.3, 1, 3 and 5.6 mg/kg Twice daily for three days To evaluate the effect of L-655708 on the alcohol deprivation effect, results showed that L-655708 dose-dependently inhibited expression of the ADE. Neuropharmacology. 2021 Nov 1;199:108785

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

2.93mL

0.59mL

0.29mL

14.65mL

2.93mL

1.46mL

29.29mL

5.86mL

2.93mL

Dissolving Methods
Please choose the appropriate dissolution scheme according to your animal administration guide.For the following dissolution schemes, clear stock solution should be prepared according to in vitro experiments, and then cosolvent should be added in turn:

in order to ensure the reliability of the experimental results, the clarified stock solution can be properly preserved according to the storage conditions; The working fluid for in vivo experiment is recommended to be prepared now and used on the same day;

The percentage shown in front of the following solvent refers to the volume ratio of the solvent in the final solution; If precipitation or precipitation occurs in the preparation process, it can be assisted by heating and/or ultrasound.
Protocol 1
Protocol 2

References

 

Historical Records

Categories